Alzamend Neuro (ALZN) Convertible Debt (2021)
Alzamend Neuro (ALZN) posted Convertible Debt of $344,893 for fiscal Q2 2022 (quarter ended Oct 31, 2021), up 1.4% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Convertible Debt (2021) Analysis & Trends
At the end of FY2021 (ended Apr 30, 2021), Alzamend Neuro's Convertible Debt came in at $335,303.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2021 | 344,893.00 |
| Jul 31, 2021 | 340,098.00 |
| Apr 30, 2021 | 335,303.00 |
API Access
Alzamend Neuro Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();